ArticleReproduction & fertility2024
Impact of prior levonorgestrel intrauterine device use at the time of embryo transfer.
Article in Reproduction & fertility, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prior copper intrauterine device use and reproductive outcomes after embryo transfer in IVF/ICSI cycles: a propensity score-matched cohort study.Frontiers in cell and developmental biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abstract: Our objective is to investigate whether infertile women with a history of levonorgestrel intrauterine device (LNG IUD) use have impaired endometrial growth and pregnancy rates after embryo transfer. This is a retrospective cohort study at a single academic medical center of infertile women aged 18-44 with a history of LNG IUD use undergoing their first embryo transfer cycle between January 2019 and January 2021 compared to controls with a history of no prior birth control use (NONE) or prior oral contraceptive (OCP) use. The primary outcome is endometrial thickness prior to embryo transfer. Secondary outcomes are embryo transfer results, including implantation, miscarriage and live birth. Demographic, baseline and cycle characteristics were similar among the three groups. Women with a history of LNG IUD use had thinner endometrial stripes than women with a history of NONE (LNG IUD: 8.93 mm, NONE: 10.32 mm (aRR: 0.88, 95% CI: 0.80-0.97)) but not when compared to women with a history of OCP use (OCP: 9.61 mm (aRR: 0.92, 95% CI: 0.84-1.01)). Women with a history of LNG IUD use had slightly higher implantation rates than those with NONE history (LNG IUD: 43.37%, NONE: 24.17% (relative risk (RR): 1.79, 95% CI: 1.21-2.45)), though not when compared to prior OCP users (OCP: 38.72% (RR: 1.12, 95% CI: 0.86-1.47)). The remainder of the embryo transfer outcomes were similar among the three groups. In conclusion, prior LNG IUD users have a reduced endometrial thickness at the time of embryo transfer but do not have worse pregnancy outcomes. Lay summary: LNG IUDs (brand names include Mirena, Liletta and Skyla) are some of the most widely used forms of birth control. While these devices are safe and are generally not believed to impact fertility, a few recent articles have suggested the possibility of a long-term impact of prior intrauterine device use on the uterine lining in some patients. As such, we sought to examine uterine lining growth and outcomes of assisted reproduction in an infertile patient population with a history of LNG IUD use compared to infertile women without a history of LNG IUD use. Ultimately, we found that women with a history of LNG IUD use had less uterine lining growth during assisted reproduction cycles, but that they did not have worse pregnancy outcomes when compared to women without a history of levonorgestrel device use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.